Introduction
============

Deep brain stimulation (DBS) is a well-established therapy for movement disorders including essential tremor, Parkinson's disease, and dystonia ([@aww145-B8]; [@aww145-B65]; [@aww145-B107]). Stimulation of the ventralis intermedius thalamic nucleus (VIM) has proven to be particularly effective for patients with essential tremor, for whom DBS can cause reductions in tremor severity that persist for years or even decades following surgery ([@aww145-B94]; [@aww145-B106]; [@aww145-B6]). Essential tremor is a disorder with a strong familial component, characterized primarily by a kinetic tremor predominantly affecting the arms, head, and/or voice that occurs during voluntary movements, including writing, eating, and other daily activities ([@aww145-B72]). The disease is thought to be driven by pathological oscillations within a tremor-related network involving motor-related frontal cortex \[sensorimotor, premotor cortex, and supplementary motor area (SMA)\], VIM, inferior olivary nucleus, cerebellar cortex and dentate nucleus ([@aww145-B30]; [@aww145-B75]; [@aww145-B88]; [@aww145-B101]).

Recent functional MRI studies have unveiled structural and functional alterations throughout the cerebello-thalamo-cortical circuit that support the notion that essential tremor is a disorder of pathological network activity ([@aww145-B18]; [@aww145-B40]). As the clinical effects of stimulating VIM are comparable to those that have been achieved by thalamic lesioning, it was originally proposed that DBS exerts its effects through local inhibition ([@aww145-B10]; [@aww145-B13]; [@aww145-B9]; [@aww145-B31]), thereby blocking pathological oscillations occurring between cerebellum and motor cortex. However, PET studies ([@aww145-B20]; [@aww145-B87]; [@aww145-B46]) and mathematical models ([@aww145-B76], [@aww145-B77]) have shown that therapeutic VIM DBS results in neural activation within distal nodes of the cerebello-thalamo-cortical circuit, suggesting that DBS may exert its effects through a more complex mechanism involving multiple oscillators within the tremor network. Indeed, studies that have combined functional MRI with DBS have shown that the therapy is able to induce changes in functional and effective connectivity across neural networks ([@aww145-B55], [@aww145-B56]; [@aww145-B61]; [@aww145-B41]) in a manner that is dependent on the applied stimulation parameters ([@aww145-B59]; [@aww145-B82]; [@aww145-B41]). However, the question of how changes in blood oxygen level-dependent (BOLD) signal induced by thalamic DBS are related to the clinical effects of the therapy has yet to be addressed.

In this study, we applied intraoperative functional MRI during VIM DBS in patients with essential tremor to test the hypothesis that the observed DBS-evoked changes in functional and effective connectivity would yield predictive information about clinical outcomes, thereby providing insights into the therapeutic mechanism. In addition, studying anaesthetized patients afforded us the unprecedented opportunity to systematically study the effects of adverse effect-inducing DBS on brain networks. By varying the location of the active contacts on the DBS lead in each subject during the experiment, we were able to apply stimulation settings that did and did not induce a common unwanted sensory adverse effect (paraesthesia) that can be induced by VIM DBS. Our results provide a missing link between the network-level changes induced by thalamic DBS and both the therapeutic and adverse effects of the therapy, and contradict the notion that thalamic DBS ameliorates tremor merely through local inhibition of the thalamus.

Materials and methods
=====================

Patients
--------

Ten patients (eight females; mean age: 69.3 ± 7.9 years) diagnosed with essential tremor underwent bilateral VIM DBS stereotactic surgery. The diagnosis of essential tremor was based on the Movement Disorders Consensus Criteria ([@aww145-B201]). All patients were approved for surgery by the Mayo Clinic DBS Committee, which is composed of neurologists, neurosurgeons, psychiatrists, neuropsychologists, speech pathologists, and a biomedical ethicist. In all patients, tremor predominantly affected the bilateral upper extremities, and in some patients tremor also affected the head, jaw, and/or voice ([Table 1](#aww145-T1){ref-type="table"}). This study was approved by the Mayo Clinic Institutional Review Board, and all patients provided written informed consent in accordance with the Declaration of Helsinki. Table 1Patient informationPatient \#AgeSexHanded nessOther regions affected by ET (in addition to bilateral upper extremities)Tremor medications at time of surgeryFTM (preoperative)FTM (3 months postoperative) (% change)Active DBS lead during FMRIUnilateral FTM score (preoperative; contralateral to active DBS lead)Unilateral FTM score (3 months postoperative) (% change)Studied DBS lead: stimulation parameters at 3 months[^a^](#aww145-TF2){ref-type="table-fn"}178FRightHead, voiceClonazepam136 (−54%)right53 (−40%)C+ 2− 60 μs, 130 Hz, 3.0 V254FRightHead, voice, upper trunkPrimidone, propranolol197 (−63%)right83 (−63%)1+ 3− 60 μs, 180 Hz, 1.15 V368FLeftHeadPrimidone, topiramate337 (−79%)right151 (−93%)C+ 1− 60 μs, 130 Hz, 1.4 V473FRightHead, voiceNone193 (−84%)right80 (−100%)C+ 0− 60 μs, 130 Hz, 0.8 V574FRightJawPropranolol, gabapentin176 (−65%)right93 (−67%)C+ 3− 60 μs, 130 Hz, 2.0 V657FRightHeadTopiramate122 (−83%)right42 (−50%)C+ 2− 60 μs, 130 Hz, 1.6 V761MLeftHeadGabapentin153 (−80%)left20 (−100%)C+ 2− 60 μs, 130 Hz, 1.45 V860FRightVoicePrimidone, propranolol84 (−50%)left42 (−50%)C+ 2− 60 μs, 130 Hz, 2.1 V962FRightHead, voiceGabapentin, primidone, propranolol93 (−67%)right42 (−50%)C+ 3− 60 μs, 130 Hz, 2.0 V1066MRightNonePropranolol183 (−83%)right101 (−90%)2+3− 60 μs, 130 Hz, 1.9 V[^2][^3]

Operative approach
------------------

Each patient was secured within the Leksell^TM^ stereotactic head frame (Elekta) and a 1.5 T structural MRI (General Electric Signa HDx, 16x software) scan was performed prior to implantation using magnetization-prepared rapid acquisition gradient-echo (MP-RAGE) sequence ([@aww145-B41]). The MRI data were merged with the Schaltenbrand and Wahren human atlas ([@aww145-B98]), and stereotactic coordinates were identified for the VIM. Following microelectrode recording, quadripolar DBS electrodes (3387 Medtronic) were implanted bilaterally under local anaesthesia. Lead placement was confirmed by computed tomography (Sensation 64, Siemens): image resolution: 0.59 × 0.59 × 1.00 mm^3^. *Post hoc* analysis of CT-MR fusion data ([Supplementary Fig. 1](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)) confirmed that the mean location and standard deviation of the most ventral DBS contact (contact 0) across our subjects was 15 ± 2.4 mm lateral; 18 ± 2.3 mm posterior; 5 ± 4 mm inferior to the anterior commissure in Montreal Neurological Institute (MNI) stereotactic coordinates. When displayed with reference to a human brain atlas ([@aww145-B33]), the region of thalamus occupied by the 40 DBS contacts studied was centred on motor thalamus (VIM) ([Supplementary Fig. 1](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)).

Intraoperative functional MRI: data acquisition
-----------------------------------------------

The intraoperative functional MRI experiment was performed during pulse generator implantation surgery, 1 week after the DBS lead implantation surgery (for detailed methods, see [@aww145-B41]). After general anaesthesia induction, a unilateral DBS lead was externalized under sterile conditions and attached to a custom wire connected to an external pulse generator (DualScreen 3628 Medtronic, Medtronic) outside the sterile field. To minimize the effects of susceptibility artefacts produced by subgaleal connectors, the laterality (right in eight patients, left in two patients) of the connected lead was selected such that it was contralateral to the implantable pulse generator ([@aww145-B41]). Patients were then moved into the magnet bore and all scans were conducted with patients under general anaesthesia ([@aww145-B41]). Average head specific absorption rate (SAR) values of \<0.1 W/kg were recorded during the functional MRI study in all the patients, and a board-certified MRI physicist with expertise in MRI for patients with implanted electronic devices was present during all the sessions ([@aww145-B202]). An anesthesia team was also present during all sessions and vital signs were continuously monitored. For all sequences, a manufacturer's standard transmit/receive RF head coil was used (1.5-T quadrature head coil, model 46-28211862; GE Healthcare). The functional MRI was acquired using 2-dimensional gradient echo-echo planar imaging (GE-EPI): repetition time/echo time, 3000/50; flip angle, 90°; field of view, 22 × 22 cm; matrix, 64 × 64; slice thickness, 3.5 mm with a 0-mm gap thickness. For each acquisition, 135 volumes (the first five volumes were discarded for scanner equilibration) were acquired using a block paradigm, with five 6-s stimulation periods (two volumes) alternated with six 60-s rest periods (20 volumes), for a total time of 6 min 45 s per run. Each patient underwent four runs of functional MRI in a single session with 2 min of rest between each run. During each run, bipolar DBS was applied at 90 μs, 130 Hz, 3 V, with the following contact configurations applied across the four runs in a counterbalanced order: 3−2+, 2−1+, 1−2+, 0−1+. By convention, contact '0' refers to the most ventrally-located contact on the quadripolar DBS lead, contact '3' is the most dorsally-located. The cathode or current source is denoted by '−', and '+' refers to the passive/return contact. Following functional MRI, patients were returned to the operating room for pulse generator implantation.

Clinical evaluation
-------------------

All clinical evaluations were supervised by a neurologist with subspecialty training in movement disorders. During the week following pulse generator implantation (1--2 weeks following DBS lead implantation), patients underwent DBS programming and clinical evaluation. The adverse effect evaluations were performed using monopolar settings used during the routine DBS programming protocol at our institution. Unilateral monopolar stimulation at each cathode (0−, 1−, 2−, 3−; 130 Hz 60 μs) was applied and amplitude was increased until patients reported experiencing an adverse effect, or to 3 V in the case that no adverse effects were reported. In three patients, we confirmed that monopolar stimulation at pulse width of 60 µs (i.e. 0− Case+ 130 Hz 60 µs) resulted in DBS-evoked paraesthesias at the same stimulation amplitude as bipolar stimulation at 90 µs (i.e. 0− 1+ 130 Hz 90 µs) (data not shown). Following adverse effect evaluation, patients underwent routine clinical DBS stimulator optimization and returned at 1 month and 3 months for subsequent programming visits. Tremor severity was evaluated preoperatively, and at each patient's 3 month programming visit, using a modified version of the Fahn-Tolosa-Marin (FTM) tremor rating scale Part A ([@aww145-B34]), which is routinely used to evaluate the therapeutic effects of tremor at our institution. Tremor severity contralateral to the DBS lead that was active during functional MRI was calculated as the sum of six subscores from upper and lower extremities contralateral to the active lead: upper extremity at rest, upper extremity during extension, upper extremity during flexion, upper extremity during finger-to-nose task (kinetic tremor), lower extremity at rest, and lower extremity during extension. The long-term clinical effectiveness of each DBS electrode studied in the functional MRI experiment was calculated as the per cent change in contralateral FTM score at 3 months relative to the preoperative value for each subject.

Functional MRI processing
-------------------------

Functional MRI data were preprocessed and analysed using AFNI (Analysis of Functional NeuroImages; <http://afni.nimh.nih.gov>) software packages ([@aww145-B25]). Prior to processing, image data from two subjects who received left-sided stimulation were flipped with respect to the mid-sagittal plane in order to generate group activation maps with a consistent (right-sided) stimulation lateralization. The high-resolution T~1~ anatomical image was aligned to the fifth volume of the EPI time series by affine registration using a local Pearson correlation cost function ([@aww145-B96]). The first four volumes of the time series were removed to ensure that all remaining volumes in the time-series were at magnetization steady state. Despiking and rigid body registration were used to estimate subject movement during EPI scans and to correct for slice acquisition timing ([@aww145-B26]). In all subjects, estimated displacement due to head motion was \<0.5 mm in any given axis between successive time series volumes. The time series were then spatially transformed to the Talairach N27 brain template ([@aww145-B51]) via affine transformation matrices estimated by registering T~1~-images to the N27 template. The spatially normalized EPI data were intensity scaled, and smoothed by a typical Gaussian blur of 6 mm full-width at half-maximum.

At the individual session level, the general linear model estimated the shape of the haemodynamic response with respect to the timing of stimulation. To account for baseline drift and residual motion artefact, regressors included six motion parameters estimated during coregistration and a third-order baseline drift function. A regressor was created for the above-mentioned blocked stimulation paradigm, and convolved with a gamma-variate haemodynamic response function. Following the general linear model process, 40 beta-coefficient activation maps were obtained for the entire subject group (four contact-wise activation maps for each individual subject). To obtain the stimulation-evoked activation map, a group-level linear mixed-effects model was conducted to adjust for within-subject activation baselines and the age effect ([@aww145-B22]) ([Supplementary Fig. 2](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)A).

Correlation between deep brain stimulation-evoked activation and the therapeutic effect
---------------------------------------------------------------------------------------

For correlation analysis, we defined regions of interest from the group activation map thresholded at a significance level of false discovery rate (FDR) q \< 0.05 (*P \<*0.002, t \> 3.41). Beta coefficients were extracted from individual activation maps, averaged within each region of interest, and Pearson correlations between region of interest-averaged beta values and the per cent change in contralateral FTM scores at 3 months for each subject were calculated. Correlations were also assessed between region of interest-averaged beta values and per cent change in contralateral FTM subscores representing postural tremor (upper extremity extended + upper extremity flexed + lower extremity extended) and upper extremity kinetic tremor, respectively. In addition, individual voxels that exhibited correlations between beta values and per cent change in contralateral FTM scores are reported. For this analysis, Monte Carlo simulation indicated that an initial, voxel-wise threshold of *P \<*0.01 and a minimum cluster size of 654 voxels gave a corrected *P*-value of 0.01 (α = 0.01; two-tailed *P \<*0.01; Pearson *r* \> 0.403; cluster size ≥ 654 voxels).

Deep brain stimulation-evoked adverse effect map
------------------------------------------------

Based on the results of clinical evaluation, activation maps were categorized into two groups: stimulation localizations at which patients reported experiencing DBS-evoked paraesthesias at or below 3 V, and those for which patients were paraesthesia-free at and below 3 V. A group-level linear mixed-effects model was conducted to examine between-group differences in response to the adverse effect. The model included the age as a between-subject covariate and contact conditions as within-subject covariates ([Supplementary Fig. 2](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)B). Monte Carlo simulation indicated that an initial, voxel-wise threshold of *P \<*0.01 and a minimum cluster size of 654 voxels gave a corrected *P*-value of 0.01 (α = 0.01, t \> 2.92) for the significance level of the group difference between DBS evoked activations with and without paraesthesias.

Dynamic causal modelling
------------------------

Deterministic, one-state dynamic causal modelling for functional MRI in SPM12 (Wellcome Trust Centre for Neuroimaging, London, UK; <http://www.fil.ion.ucl.ac.uk>) was used to investigate effective connectivity among established nodes in the tremor-related cerebello-thalamo-cortical loop. BOLD time series data from within a 6-mm sphere centred on the group peak voxel of activation for sensorimotor cortex, thalamus, and contralateral cerebellum ([Fig. 2](#aww145-F2){ref-type="fig"}) were included in the analysis. A model representing the established loop, in which VIM thalamus connects reciprocally with motor cortex and contralateral cerebellum, with DBS driving thalamic output, was defined. In one state dynamic causal modelling, connections between brain regions are modelled as excitatory projections, while each region is endowed with inhibitory self-connectivity ([@aww145-B38]). The parameters that represent the strength of between-region (excitatory) and within-region (inhibitory) connections, as well as the driving effect of DBS on the thalamus, are estimated using a posterior density analysis scheme under Gaussian assumptions ([@aww145-B37]). The estimated between- and within-region parameters, given in per second units, or Hertz, describe the degree to which activity in one area is sensitive to changes in activity in another, and has been likened to the concept of electronic gain ([@aww145-B55]). Inter-regional and within-region connectivity parameters were computed for each subject for each run (40 runs total). Parameter values determined to be significantly different from zero (one sample *t*-test, *P* \< 0.05) are reported as 95% confidence intervals (CI). Finally, to determine whether within- or between-region connectivity, as estimated by dynamic causal modelling, correlated with the clinical response, Pearson correlations were assessed between significant between- and with-region connectivity parameters and per cent reduction in contralateral FTM scores. Figure 1**Therapeutic and adverse effects of DBS.** (**A**) Bilateral and contralateral FTM scores, before (blue) and 3 months after surgery (red) (\**P \<*0.05, Wilcoxon signed rank). (**B**) Maximum DBS amplitudes tolerated without the presence of adverse effects during clinical evaluation. When no adverse effects were present, stimulator amplitude was increased to 3 V. (**C**) Body areas affected by DBS-evoked paraesthesias, for each stimulation localization (UE = upper extremity). Figure 2**Group activation map evoked by VIM DBS and region of interest-level correlations**. DBS resulted in significant BOLD activation (FDR q \< 0.05; *P \<*0.002, t \> 3.41) in (**A**) ipsilateral sensorimotor cortex, (**B**) ipsilateral thalamus, and (**C**) contralateral cerebellum. Significant correlations between region of interest-averaged beta values and contralateral per cent reduction in contralateral FTM score were observed (*P \<*0.05) in all three areas.

Results
=======

Therapeutic and adverse effects of deep brain stimulation
---------------------------------------------------------

At 3 months, patients experienced a significant reduction in tremor severity, both bilaterally (*P* = 0.0098, Wilcoxon signed rank) and contralateral to the DBS lead that was active during the functional MRI experiment (*P =*0.002, Wilcoxon signed rank) ([Fig. 1](#aww145-F1){ref-type="fig"}A). Contralateral reductions in tremor severity ranged from 40 to 100% (median: 65%). Median stimulation parameters for the studied DBS lead at 3 months were 60 μs 130 Hz 1.75 V ([Table 1](#aww145-T1){ref-type="table"}). Of the 40 stimulation localizations that were tested, 23 were associated with stimulation-evoked paraesthesias. These occurred at a median amplitude of 2.0 V (range: 0.6 V to 3 V) ([Fig. 1](#aww145-F1){ref-type="fig"}B), and affected the contralateral face (18 settings), contralateral upper extremity and hand (11 settings), and tongue (nine settings) ([Fig. 1](#aww145-F1){ref-type="fig"}C). Paraesthesias were most commonly reported at contact 0 (in 9/10 patients), and least commonly reported at contact 3 (in 2/10 patients). Other adverse effects included contraction of facial muscles (two settings) and dysarthria (four settings).

Deep brain stimulation-evoked activation of cerebello-thalamo-cortical circuit correlates with therapeutic effectiveness
------------------------------------------------------------------------------------------------------------------------

The general effect of DBS resulted in three clusters of significant BOLD activation, located in ipsilateral sensorimotor cortex ([Fig. 2](#aww145-F2){ref-type="fig"}A), thalamus ([Fig. 2](#aww145-F2){ref-type="fig"}B), and contralateral cerebellum ([Fig. 2](#aww145-F2){ref-type="fig"}C). Region of interest-level correlation analysis revealed significant positive correlations between therapeutic effectiveness and the extent of BOLD activation in sensorimotor cortex (*P =*0.040, r = 0.33), thalamus (*P =*0.032, r = 0.34), and contralateral cerebellum (*P =*0.0007, r = 0.52) ([Fig. 2](#aww145-F2){ref-type="fig"}). Analysis with reference to the Eickhoff-Zilles atlas ([@aww145-B33]) showed that the cerebellar region of interest spanned deep cerebellar nuclei, and lobules V, VI, VIIIa, and IX ([Supplementary Fig. 3](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)). Significant voxel-wise correlations were also observed in sensorimotor cortex, thalamus, and contralateral cerebellum, as well as in supplementary motor area, brainstem, and contralateral inferior frontal gyrus ([Fig. 3](#aww145-F3){ref-type="fig"}). Finally, a significant region of interest-level correlation between BOLD activation and per cent change in contralateral FTM subscores related to postural tremor was observed in sensorimotor cortex (*P =*0.017, r = 0.39), while no kinetic tremor-related region of interest-level correlations were observed ([Supplementary Fig. 4](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)). Figure 3**Voxel-level correlations with therapeutic effect.** Regions of interest (ROIs) defined in [Fig. 2](#aww145-F2){ref-type="fig"} are shown in red, and regions where voxel-level correlations overlapped with these regions of interest (yellow) and regions in which voxel-level correlations but no significant activation across the group was observed (blue) are shown. Monte Carlo simulation indicated that an initial, voxel-wise threshold of *P \<*0.01 and a minimum cluster size of 654 voxels gave a corrected *P*-value of 0.01 (α = 0.01; two-tailed *P \<*0.01; Pearson *r* \> 0.403; cluster size ≥ 654 voxels). Region of interest-level correlations in the motor circuit (**A**--**C**) were robust, indicating that the region of interest-level analyses ([Fig. 2](#aww145-F2){ref-type="fig"}) are sufficient to capture the major brain--behaviour correlations present in this study. SMC = sensorimotor cortex; IFG = inferior frontal gyrus.

Intrinsic cerebellar connectivity correlates with therapeutic response
----------------------------------------------------------------------

DBS exerted an excitatory driving effect (95% CI: 0.06--0.23 Hz, *P =*0.0013) on the thalamus, which displayed significant excitatory effective connectivity with ipsilateral sensorimotor cortex (95% CI: 0.08--0.24 Hz, *P =*0.0004) and contralateral cerebellum (95% CI: 0.04--0.12 Hz, *P =*0.0004) ([Fig. 4](#aww145-F4){ref-type="fig"}A and B). In addition, significant inhibitory within-region connectivity was observed in cerebellum (95% CI: −0.033--−0.007 Hz, *P =*0.0027\] ([Fig. 4](#aww145-F4){ref-type="fig"}A and B). Attenuated inhibitory within-region connectivity in cerebellum correlated with improved contralateral reduction in tremor severity at 3 months (r = 0.34, *P =*0.03) ([Fig. 4](#aww145-F4){ref-type="fig"}C). Figure 4**Dynamic causal modelling results.** (**A**) Excitatory interregional (blue arrows) and inhibitory within-region (red arrows) connections between sensorimotor cortex (SMC), motor thalamus (VIM), and contralateral cerebellum (CC), and the driving effect of DBS on VIM yellow are shown overlaid on the group DBS-evoked activation map. Connectivity parameters significantly different from zero are shown in **A**, and the estimated values for all connectivity parameters are shown in **B** (\**P \<*0.05, ^\*\*^*P \<*0.001). (**C**) A significant correlation (*P \<*0.05) was observed between within-region inhibitory connectivity in contralateral cerebellum and percent reduction in contralateral tremor score.

Deep brain stimulation-evoked activation of subregions of pre- and postcentral gyri correlate with the presence of paraesthesia
-------------------------------------------------------------------------------------------------------------------------------

A single region of interest was identified within sensorimotor cortex in which increased BOLD activation was associated with the presence of DBS-evoked paraesthesia ([Fig. 5](#aww145-F5){ref-type="fig"}). This region of interest overlapped with a larger region representing the general effect of DBS-evoked activation, which spanned pre-, postcentral gyri and sulci, as well as the subcentral area ([Fig. 5](#aww145-F5){ref-type="fig"}). The region of interest associated with DBS-evoked paraesthesia included subregions of lateral precentral gyrus, central sulcus, postcentral gyrus, and postcentral sulcus ([Fig. 5](#aww145-F5){ref-type="fig"}). Figure 5**Subregions of sensorimotor cortex associated with the presence of DBS-evoked paraesthesia.** These subregions (coloured in purple) are shown with reference to the sensorimotor region of interest corresponding to the general effect of DBS (coloured in pink) overlaid on N27 human brain template (*left*) and its inflated cortical surface (*right*). The area boundaries were mapped from the FreeSurfer cortical parcellation map ([@aww145-B36]), and the deepest points of central sulcus are represented by the dashed line.

Discussion
==========

Our central finding was that the extent of functional activation in all of the established nodes of the tremor circuit (sensorimotor cortex, SMA, thalamus, cerebellum, and brainstem) correlated with the long-term therapeutic effectiveness of DBS. According to current theory, essential tremor is likely driven by multiple central oscillatory generators throughout the cerebello-thalamo-cortical circuit that dynamically entrain with one another to produce symptoms of essential tremor ([@aww145-B93]; [@aww145-B101]; [@aww145-B92]). The VIM projects to motor and premotor cortices, and is functionally subdivided into a posterior circuit that receives afferents from the cerebellar dentate nucleus ([@aww145-B4]), and an anterior circuit that primarily receives afferents from the basal ganglia ([@aww145-B63]). Therefore, while VIM is situated to modulate all components of the tremor-related cerebello-thalamo-cortical network, our results suggest that network-wide modulation, as opposed to activation of a single brain region or fibre tract, may mediate the therapeutic effects.

The VIM was originally selected as a target for lesioning ([@aww145-B50]), and later DBS ([@aww145-B8]), primarily due to its established connectivity with olivocerebellar circuits. The cerebellum has long been thought to play a role in the emergence of essential tremor, due to human neuroimaging ([@aww145-B24]; [@aww145-B54]) and animal model electrophysiology data ([@aww145-B66], [@aww145-B67]). However, more recent experiments have begun to also implicate motor-related thalamocortical circuits in the mechanism of tremor generation. Studies combining EEG or MEG with EMG recordings have identified tremor-coherent oscillations in motor and premotor cortex ([@aww145-B48]; [@aww145-B93]; [@aww145-B101]), and coherence and time delay analyses between EEG/MEG recordings and EMG signals have revealed that these oscillations likely reflect cortical output rather than simply sensory feedback ([@aww145-B42]; [@aww145-B100]). In addition, single-pulse suprathreshold transcranial magnetic stimulation (TMS) of motor cortex has a known ability to reset tremor ([@aww145-B15]; [@aww145-B85]), and continuous TMS can reduce tremor amplitude in patients ([@aww145-B47]). Intraoperative recordings have demonstrated that tremor-related thalamic oscillatory activity is much more likely to occur during movement ([@aww145-B52]), and local field potentials in the thalamus are coherent with electromyography data during muscle contraction but not at rest ([@aww145-B73]). Together, these results suggest that sensorimotor cortex plays an active role in the production of tremor-related oscillations, rather than simply receiving constant tremor-related olivocerebellar input. Accordingly, our results suggest that DBS brings about its therapeutic effects in part by modulating motor cortex. This hypothesis is also supported by a recent diffusion tensor imaging study, which found that therapeutically effective thalamic DBS preferentially targets thalamic subregions that display enhanced structural connectivity with primary motor cortex ([@aww145-B60]).

While our results implicate thalamocortical afferents in the therapeutic effect, the strongest correlation between DBS-evoked BOLD activation and clinical response was observed in the contralateral cerebellum. Clinical and experimental evidence has consistently implicated cerebellar dysfunction in the pathophysiology of essential tremor. Patients can present with signs of cerebellar dysfunction, including intention tremor ([@aww145-B29]), balance and gait impairment ([@aww145-B105]; [@aww145-B62]), motor speech impairment ([@aww145-B62]), and eye movement abnormalities ([@aww145-B49]). Numerous functional neuroimaging studies have reported cerebellar hyperactivity ([@aww145-B24]; [@aww145-B54]; [@aww145-B109], [@aww145-B108]; [@aww145-B17]; [@aww145-B11]) and metabolic abnormalities ([@aww145-B70]; [@aww145-B83]) in essential tremor, and structural changes including atrophy ([@aww145-B91]; [@aww145-B21]) and reduced fractional anisotropy ([@aww145-B80]). While the origin of these abnormalities remains incompletely understood, Purkinje cells, which provide GABAergic innervation to the dentate nucleus from cerebellar cortex, may play a central role. Post-mortem histological studies have identified axonal and dendritic swelling ([@aww145-B69], [@aww145-B68]; [@aww145-B113]) and heterotopic displacement in Purkinje cells in essential tremor ([@aww145-B64]), and some studies have associated reduced Purkinje cell numbers with the disease ([@aww145-B69]; [@aww145-B5]; [@aww145-B103]). The correlation reported in this study spanned a region of interest that included deep cerebellar nuclei, as well as cerebellar cortex. The activated region of cerebellar cortex primarily involved a region (lobule VI) displaying connectivity with motor and premotor cortices. Our result therefore suggests that DBS-evoked modulation of motor-related cerebellar outflow, mediated by Purkinje cells, may play an important role in the mechanism of VIM DBS.

In further support of this hypothesis, our effective connectivity analysis revealed a correlation between attenuated within-region inhibitory cerebellar connectivity and the therapeutic effectiveness. Previous reports have suggested that essential tremor is in fact a heterogeneous disease, and degeneration of deep cerebellar nuclei is only seen in a subset of patients ([@aww145-B71], [@aww145-B69]). Therefore, it is possible that VIM DBS yields greater therapeutic responses (i) in patients in whom Purkinje dysfunction plays a more prominent role in the disease state; or (ii) in patients who received DBS that more effectively targets cerebellar outflow neurons of the dentato-rubro-thalamic tract. In line with the latter hypothesis, efficient targeting of the dentato-rubro-thalamic tract has been correlated with improved outcomes in tremor patients receiving subthalamic nucleus DBS ([@aww145-B43]). It has been hypothesized that GABAergic deficiency in the dentate nucleus may drive tremor-associated oscillations through disinhibition of cerebellar efferents ([@aww145-B84]). We therefore speculate that DBS-evoked activation in deep cerebellar nuclei may be accompanied by an increase in GABAergic tone in the dentate. Indeed, the ability of DBS to result in GABA release distal to the site of stimulation has been previously demonstrated ([@aww145-B112], [@aww145-B111]). It has also been shown that activation of thalamic A1 receptors can result in therapeutic effects on tremor, suggesting that the effects of DBS on cerebellar inhibition may also be mediated by adenosine release ([@aww145-B7]). Further work will be needed to elucidate the precise mechanisms by which VIM DBS modulates tremor-related neurotransmitter concentrations and neural activity in the cerebellum.

Although DBS did not result in significant activation in the brainstem across the subjects studied, a voxel-level correlation between brainstem activation and therapeutic effectiveness was observed ([Fig. 3](#aww145-F3){ref-type="fig"}). This result may in part represent DBS-evoked modulation of the inferior olivary nucleus. The neurons of the inferior olivary nucleus send climbing fibre afferents to communicate with Purkinje cells by way of the inferior cerebellar peduncle ([@aww145-B28]), which then synapse on GABAergic dentato-olivary projections in the deep cerebellar nuclei ([@aww145-B3]). This dentato-olivary loop has been shown to influence cerebellar output during motor tasks ([@aww145-B108]), and this circuit has been proposed to drive synchrony among Purkinje cells ([@aww145-B45]), leading tremor activity to propagate throughout the cerebello-thalamo-cortical circuit. Functional imaging studies have not identified a consistent metabolic alteration in the inferior olivary nucleus in essential tremor patients ([@aww145-B44]; [@aww145-B109]; [@aww145-B17]). However, ethanol-induced tremor reduction is associated with inferior olivary nucleus activation ([@aww145-B12]), and the harmaline-induced animal model of essential tremor is known to be mediated by drug-induced bursting activity in the inferior olivary nucleus ([@aww145-B66], [@aww145-B67]). The observed correlation provides evidence that the effects of DBS may extend beyond the dentate nucleus to affect the entire olivocerebellar circuit.

A voxel-wise correlation was also observed in the ipsilateral SMA. Several lines of evidence suggest that the SMA may represent another important node in the tremor circuit. Increased grey matter volume in SMA and reduced functional connectivity between SMA and motor cortex has been shown to correlate with tremor severity in patients with essential tremor ([@aww145-B40]). In addition, tremor-coherent activity has been detected by MEG in premotor areas ([@aww145-B101]), and abnormal activation in SMA has been observed during motor tasks in tremor patients ([@aww145-B79]). It is difficult to speculate regarding the mechanism by which VIM DBS may modulate SMA, since this region displays connectivity with both motor cortex ([@aww145-B32]) and cerebellum ([@aww145-B1]; [@aww145-B14]), and receives thalamocortical projections from the anterior portion of VIM ([@aww145-B99]). Repetitive non-invasive cerebellar stimulation has been shown to alter connectivity between cerebellum and SMA ([@aww145-B90]), potentially implicating modulation of long-range fibres. Our results suggest that thalamic DBS may also modulate these connections.

The only correlation observed outside of the cerebello-thalamo-cortical circuit was located in the contralateral inferior frontal gyrus. As the group activation map mainly represents the effects of right-sided stimulation (8/10 electrodes), this brain region likely represents the left inferior frontal gyrus. Also known as Broca's area ([@aww145-B16]), it is thought to play a critical role in processing both the phonological aspects and meanings of words ([@aww145-B39]; [@aww145-B53]), and therefore is essential for language production and comprehension. Interestingly, high frequency thalamic stimulation for tremor has been shown to cause impairments in verbal fluency, while low frequency stimulation enhances fluency ([@aww145-B203]). Stimulation-evoked fluency impairments have also been observed following subthalamic nucleus DBS in patients with Parkinson's disease, and PET studies in these patients have correlated this effect with decreased activation in prefrontal regions that include Broca's area ([@aww145-B102]; [@aww145-B23]; [@aww145-B57]). These findings, coupled with the observation that thalamic DBS induces prefrontal activation in animal models ([@aww145-B82]), suggest that thalamic DBS may exert unexplored effects on prefrontal circuits, particularly those involved in language. While the effect of DBS on verbal fluency was not assessed in this study, our result suggests that prefrontal BOLD correlates of the effects of stimulation on fluency may exist. However, as this correlation (as well as those in SMA in brainstem) was observed in an area that did not exhibit significant activation across the group, and it occurs in a region contralateral to the stimulated nucleus, it must be interpreted with caution.

Our analysis revealed specific subregions of sensorimotor cortex in which DBS-evoked activation correlated with the presence of paraesthesias. While a few case reports have shown differences in functional activation patterns at DBS settings that evoke cognitive and mood-related adverse effects ([@aww145-B102]; [@aww145-B104]; [@aww145-B23]; [@aww145-B57]) the hypothesis that functional MRI could identify cortical regions that mediate sensorimotor adverse effects has not been tested to our knowledge. To investigate this question, we chose the most common adverse effect induced by thalamic DBS, paraesthesia, which results from inappropriate stimulation of neurons in the ventralis caudalis nucleus (Vc), the somatosensory relay nucleus of the thalamus that resides immediately posterior to VIM. The use of intraoperative imaging in anaesthetized patients allowed us to investigate the network-level effects of paraesthesia-inducing DBS without causing patients any discomfort. Our analysis revealed that DBS-evoked paraesthesias were associated with increased activation in a region of the lateral sensorimotor cortex that spanned precentral gyrus, central sulcus, and postcentral sulcus ([Fig. 5](#aww145-F5){ref-type="fig"}). This result is supported by human intraoperative cortical mapping experiments, which have shown that both sensory and motor responses can be elicited by stimulation on either side of the central sulcus ([@aww145-B86]; [@aww145-B81]), suggesting that the traditional nomenclature (precentral gyrus = 'motor' and postcentral gyrus = 'sensory') represents an oversimplification. In addition, it is known that cutaneous stimulation can evoke responses in both pre- and postcentral gyri ([@aww145-B35]). We note that the lateral location of the region of interest associated with paraesthesias corresponds roughly to the face/hand areas of the homunculus, in line with our observation that DBS-evoked paraesthesias were most commonly evoked in the contralateral face, followed by the hand and upper extremity ([Fig. 1](#aww145-F1){ref-type="fig"}).

Some limitations and technical points must be considered. First, our DBS-functional MRI experiments were conducted while patients were under general anaesthesia. While this approach allowed us to assess the BOLD effects associated with paraesthesia-inducing stimulation, we note that anaesthesia may influence the DBS-evoked BOLD signal. Patients received both inhaled halogenated ether anaesthetic and intravenous fentanyl during functional MRI acquisition. These drugs have a known ability to depress neuronal activity and metabolism ([@aww145-B95]), and can also influence cerebral blood flow and neurovascular coupling ([@aww145-B78]; [@aww145-B97]; [@aww145-B74]). While the effects of these agents on the BOLD signal remain incompletely characterized, several studies have correlated the presence of anaesthesia with decreases in the magnitude and activation area of stimulus-evoked BOLD responses ([@aww145-B58]; [@aww145-B89]; [@aww145-B2]). We previously compared the DBS-evoked BOLD signal in awake versus anaesthetized subjects ([@aww145-B61]), and found that while similar activation areas were observed in both groups, anaesthesia was associated with reduced BOLD signal magnitude. It is therefore possible that the presence of anaesthesia resulted in an underestimation the DBS-evoked BOLD effect. The impact of anaesthesia on the correlations presented here is uncertain, and future studies will be needed to clarify this relationship. Second, the DBS electrode created a susceptibility artefact that reduced the strength of the BOLD signal along the electrode trajectory ([Supplementary Fig. 5](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)). Despite this artefact, DBS-evoked BOLD signal at the group level was still observed in the motor thalamus. It is likely, however, that the artefact led to an underestimation of DBS-evoked BOLD in the immediate vicinity of the electrodes, which may have affected the results of our correlation and effective connectivity analyses. We also note that a correlation between BOLD activation and postural, but not kinetic, tremor subscores was observed in sensorimotor cortex ([Supplementary Fig. 4](http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/aww145/-/DC1)). One possible explanation of this result is that preferential targeting of thalamocortical projections may play a more important role in suppression of postural than kinetic tremors in essential tremor. However, we must emphasize that this result is preliminary, as our clinical evaluation of kinetic tremor did not quantitatively differentiate simple kinetic tremor from intention tremor, both of which may be modulated by different mechanisms ([@aww145-B30]). In addition, our study may be underpowered to detect correlations between BOLD activation and individual tremor subtypes, and a larger sample size may be necessary to address this question. Finally, the DBS settings used during functional MRI were not identical to those applied chronically. However, this study was designed to test whether BOLD activation patterns obtained intraoperatively, before optimal stimulation parameters had been selected, exhibited correlations with future therapeutic efficacy. We note that this design precludes us from establishing a causal relationship between increased network activation and clinical effects. However, it did allow us to assess whether network activation in response to a standard set of parameters, applied prior to DBS programming, would correlate with improved future therapeutic response. As DBS expands to treat other neurological and psychiatric disorders where obvious clinical signs of efficacy cannot be immediately observed during DBS programming, there will be an increasing need for measures of brain activity, obtained prior to chronic stimulation that could be used to guide this process. While technical hurdles still exist, our results indicate that DBS-evoked BOLD activation patterns may hold untapped potential to fill this unmet need.
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BOLD =

:   blood oxygen level-dependent

DBS =

:   deep brain stimulation

FTM =

:   Fahn-Tolosa-Marin (tremor rating scale)

SMA =

:   supplementary motor area

VIM =

:   ventralis intermedius thalamic nucleus

[^1]: \***These authors contributed equally to this work.**

[^2]: ET = essential tremor; FMRI = functional MRI.

[^3]: ^a^Anode (C = case, or implantable pulse generator), cathode, pulse-width, frequency, amplitude.
